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Abstract
We consider five asymptotically unbiased estimators of intervention effects on
event rates in non-matched and matched-pair cluster randomized trials, includ-
ing ratio of mean counts (r1), ratio of mean cluster-level event rates (r2), ratio of
event rates (r3), double ratio of counts (r4), and double ratio of event rates (r5).
In the absence of an indirect effect, they all estimate the direct effect of the inter-
vention. Otherwise, r1, r2, and r3 estimate the total effect, which comprises the
direct and indirect effects, whereas r4 and r5 estimate the direct effect only. We
derive the conditions under which each estimator is more precise or powerful
than its alternatives. To control bias in studies with a small number of clus-
ters, we propose a set of approximately unbiased estimators. We evaluate their
properties by simulation and apply the methods to a trial of seasonal malaria
chemoprevention. The approximately unbiased estimators are practically unbi-
ased and their confidence intervals usually have coverage probability close to the
nominal level; the asymptotically unbiased estimators perform well when the
number of clusters is approximately 32 or more per trial arm. Despite its sim-
plicity, r1 performs comparably with r2 and r3 in trials with a large but realistic
number of clusters. When the variability of baseline event rate is large and there
is no indirect effect, r4 and r5 tend to offer higher power than r1, r2, and r3. We
discuss the implications of these findings to the planning and analysis of cluster
randomized trials.
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1 INTRODUCTION
The cluster randomized trial (CRT) is an important study design in medical and health research.1,2,3 Data on outcome
events may be collected by passive surveillance or active surveillance.4 Passive surveillance methods may or may not
provide data at the individual level. That is, they may determine only the number of events in a cluster, without identifying
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which individual members of the cluster experienced the events. Furthermore, the denominators for standard practice of
calculating event rates may not be available.4 The advantage of passive surveillance is that the monetary and opportunity
cost of data collection can be much reduced.
Broadly speaking, there are two approaches to the analysis of CRTs: individual-level analysis and cluster-level analysis.
Methods for individual-level analysis of CRTs include random-effects models and generalized estimating equations. As
compared to cluster-level analysis, individual-level analysis has the relative advantage of efficiency and ease in covariate
adjustment. However, it has the relative disadvantage of being less robust, especially when the number of clusters is
small.1 Furthermore, data collection by passive surveillance may not be compatible with individual-level analysis. In this
manuscript we consider only cluster-level analysis.
An estimator of the intervention effect in terms of incidence rate ratio, also called relative incidence, that only uses
event data is a ratio of the arithmetic mean of the number of outcome events per cluster in the intervention arm to that
in the control arm. We call this the “ratio of mean counts”, denoted by r1.
The denominator of event rates, that is, units of person-time, in CRTs is usually variable across clusters. The
person-time for estimation of an event rate is sometimes approximated by the population size at some point of the study
duration. In this article we use the phrases person-time and population size interchangeably. Typical statistical practice
makes comparison of event rates instead of mean number of events between trial arms. It requires extra resources in the
collection of person-time data. A demographic surveillance system, a population census, or rounds of community sur-
veys may be required for this purpose. With both the number of events and person-time collected for each cluster, one
may calculate a cluster-level event rate for each cluster, denoted by cij = yij∕pij, where yij and pij are the number of events
and person-time in the jth cluster in the ith trial arm, respectively. Then, the arithmetic means of the cluster-level event
rates in the intervention and control arms are calculated, denoted by c1 and c0, respectively. The ratio of the two means,
r2 = c1∕c0 is a popular estimator of the incidence rate ratio.1,5,6 This estimator has been evaluated by simulations but not













is known as “k” in the literature.5




.6 It showed that r2 was








= 0.4. Analytical investigation and
simulation evaluation in a broad range of parameter values are warranted.
An alternative estimator of incidence rate ratio can be obtained by first calculating the event rate in each trial
arm as the sum of the number of events divided by the sum of person-time over the clusters,7,8 and then calculate
the ratio of these event rate estimates between the trial arms. We call this the “ratio of event rates”, denoted by r3.
While ci (i = 0,1) is an unweighted average of cluster-level event rates in the ith trial arm, the alternative estimator
of event rate here can be seen as a weighted average of cluster-level event rates, with the clusters’ population sizes as
weights.
In CRTs, interventions are often provided only to a specific group of the cluster members instead of all cluster mem-
bers. For example, in studies of vaccines for pediatric infectious diseases, usually only young children in a specific
age range are offered the interventions or its control comparators. Older children and adults are not. We refer to the
two groups of cluster members as the target and non-target groups. The outcome events may occur in both groups. In
studies based on passive surveillance, the event data may be collected for the non-target group in addition to the tar-
get group without much additional resources required, because the capital cost and infrastructure are already invested
for the target group anyway. We consider an estimator that we call “double ratio of counts”, denoted by r4, by replac-
ing the sums of person-time in r3 by the sums of number of events in the non-target groups. Note that this estimator
is defined even if the number of events in the non-target group is zero in some clusters, which is a realistic situation
because usually the reason of it being a non-target group is that the disease incidence is relatively low. The motivation
for considering this estimator arises from not only concerns of feasibility and cost of data collection but also concerns
of precision and power. From an epidemiological point of view, sometimes we anticipate that the event counts in the
target and non-target groups are highly correlated, because they are both the manifestation of the disease burden in
the clusters. In particular, some events are highly localized, for example, infectious diseases occurring in small out-
breaks. For such events, the correlation between number of events in the target and non-target groups, say children
inside and outside a vaccination age range, is likely to be much stronger than the correlation between the number of
events and amount of person-time in the target group. This advantage in correlation offers a potential for improved pre-
cision. Note that r4 and the three estimators aforementioned have different targets of estimation (estimands): r1, r2, and
r3 estimate the total effect of the intervention whereas r4 estimates the direct effect. Details will be discussed in the next
section.
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We also propose a new estimator that we call “double ratio of event rates”, denoted by r5. It has the ratio of event rates
between the target and non-target groups in the intervention arm as the numerator and its counterpart in the control arm
as the denominator. Details in statistical notations will be provided in the next section. We hypothesize that this estimator
will out-perform r4 in precision and power.
Donner and Klar pointed out that CRTs of binary outcomes may regard a proportion as a ratio and then an
appropriate variance estimate can be obtained from sample survey theory.9 They used the ratio of this estimated
variance to the estimated binomial variance to adjust the Chi-square statistics for hypothesis testing. In the con-
text of toxicological experiments in which litters of animals were the experimental units and a binary outcome was
observed for each animal, Rao and Scott proposed using the aforementioned approach to adjust the Chi-square and
Cochran-Armitage statistics.10 There has been some subsequent research on using ratio estimators for CRTs with
event rate outcomes, including the two simulation studies of r2 aforementioned.5,6 Furthermore, Dufault and Jew-
ell proposed permutation tests of counts of events only, with or without adjustment for differential ascertainment.4
All of them concerned only CRTs that randomize clusters individually and (implicitly) aim to estimate the total
effect.
This study aims to (a) evaluate and compare the performance of the five estimators aforementioned and (b)
develop, evaluate, and compare bias-corrected version of them. In Section 2 we will analytically assess and develop
the methods. In Section 3 we will evaluate the methods by simulation in a broad range of realistic scenarios. In
Section 4 we will apply the methods to a study of seasonal malaria chemoprevention. Section 5 gives some concluding
remarks.
For brevity, we will focus on CRTs that randomize clusters individually, that is, non-matched CRTs. Where necessary
we also provide the details for matched-pair CRTs in which one cluster per matched pair is randomized to receive the
intervention and the other serves as the control. Introduction to the two types of CRTs can be found in, for example, Hayes
and Moulton1 and Donner and Klar.2
2 STATISTICAL METHODS
2.1 Intervention effects and event rates
An intervention may have a direct effect and an indirect effect, for example, via reducing disease transmission in the
community.3,11 Only the intervention’s target group can benefit from the direct effect; both the target and non-target
groups may benefit from the indirect effect, if any. Assume that:
𝛽T = 𝛽D + 𝛽I
where 𝛽T , 𝛽D, and 𝛽I are the total, direct, and indirect effects in terms of log incidence rate ratio. If there is no indirect effect,
𝛽I = 0 and 𝛽T = 𝛽D. The presence of an indirect effect depends on various factors including the nature of the interventions
and outcome events. For example, even though vaccines are often anticipated to generate some degree of indirect effect
on efficacy endpoints, they are usually anticipated to have no indirect effect on safety endpoints.
Let Yijk and Pijk be the number of events and total person-time in the kth group of the jth cluster in the ith trial arm
in the population, respectively, where k = 1 and 0 represent the target and non-target groups, respectively, i = 1 and 0
represent intervention and control trial arms, respectively. We consider a data generating process that is often used in
epidemiologic modeling, that the expected value of Yijk given Pijk is:
E
(
Yijk|Pijk) = exp (𝛽D,ik + 𝛽I,i + 𝛼ij + 𝛾k) Pijk, (1)
where 𝛽D,ik and 𝛽I,i represent direct and indirect effects (𝛽D,11 = 𝛽D; 𝛽I,1 = 𝛽I ; 𝛽D,10 = 𝛽D,01 = 𝛽D,00 = 𝛽I,0 = 0), 𝛼ij is




≥ 0 that represents variation in event rates between clus-
ters within each trial arm, and 𝛾k represents the difference in event rates between the target and non-target group








, the coefficient of variation in cluster-level event rate.5,6 By randomiza-
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2.2 Asymptotically unbiased estimators
Given a sample dataset of
{
yijk, pijk ∶ j = 1, 2, … ,ni; i = 0, 1; k = 0, 1
}
, with randomization and a large number of clusters
per trial arm, the ratio of mean counts, r1, provides an asymptotically unbiased estimator of the total effect that compares
































≈ exp (𝛽T) .















causing a small sample bias in the ratio estimator.7 This and the bias in the other estimators will be discussed in
Section 2.3.






















also provide asymptotically unbiased estimators of the total effect.
The variance of r1, r2, and r3 can be written as:5,7,8



















































)2 + CV(pij1)2 − 2CV (yij1) CV (pij1) corr (yij1, pij1)] .
















, where 0 < 𝜃i ≤ 1.















































)2] − CV(yij1)2 < 0.
MA et al. 5



















If r2 and r3 give the same estimate, Var (r2) < Var (r3)under the condition that in both trial arms Var (Ri) ∕c
2
i < Var (Ri) ∕R2i ,
that is,










approximately equals zero in real-world situations.
In contrast, with large n1,n0 and randomization, the double ratio of counts (r4) provides an asymptotically unbiased




































= exp (𝛽D) .
The variance of r4 is:





















)2 = 1ni [CV(yij1)2 + CV(yij0)2 − 2CV (yij1) CV (yij0) corr (yij1, yij0)] .
Comparisons of the variances of the estimators r2 vs r4 and r3 vs r4 are meaningful only if the indirect effect is absent or
trivial and the estimates r2 ≅ r4 and r3 ≅ r4. In Section A of Online Supplementary Material 1 we show that Var (r4) <




































A strong correlation between number of events in the target and non-target groups as compared to the correlation between
the number of events and person-time in the target group would favor r4 over r2 and r3 in terms of precision.
If a non-trivial indirect effect is present, the absolute values of the test statistics
∣ t (r2) ∣=
∣ r2 − 1 ∣√
Var (r2)
,
∣ t (r3) ∣=
∣ r3 − 1 ∣√
Var (r3)
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and
∣ t (r4) ∣=
∣ r4 − 1 ∣√
Var (r4)
are comparable in the sense that they all indicate the probability of rejecting the null hypothesis of the target ratio being


































In the special case that 𝜁 = 1 or 𝜉 = 1, Equations (11) or (12) reduce to Equations (9) and (10), respectively. Otherwise,
assume that the estimates of direct and indirect effects are in the same direction, the closer 𝜁 or 𝜉 is to 1, the more
favourable r4 is in terms of power.















, also provides an asymptotically
unbiased estimator of the direct effect. The variance of r5 is:
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It is natural to expect that the number of events is more strongly correlated with the person-time in the same group than
the other group. Therefore, we anticipate a high chance of Var (r5) < Var (r4) in many studies.
For matched-pair CRTs, n1 = n0 = n is the number of pairs of clusters. Within the jth pair of clusters, one cluster is
randomized to receive intervention (i = 1) and the other is the control cluster (i = 0). The paired design version of the five
estimators, rpairedl ( l = 1, 2, 3, 4, 5), and their variances are shown in Appendix Table A1.
2.3 Approximately unbiased estimators
The literature about bias in ratio estimators and the mitigation methods has very much focused on paired observations,
mostly concerning an estimator in the form of rpaired1 .
7,12 Rao and Pereira considered a ratio-of-ratio estimator in the form
of rpaired3 or r
paired
4 .
13 These previous works showed that the estimators have a bias of order n−1; bias-reduction methods
were proposed. Useful though they are, they do not deal with non-matched CRTs and rpaired2 and r
paired
5 .
One solution is to determine the expectation and therefore bias of a ratio estimator, and then subtract the bias from
the estimator. See, for example, van Kempen and van Vliet8 and Rao and Pereira.13 Although it has only been considered
in studies of paired observations, the concept is applicable to both non-matched and matched-pair CRTs. Following this
approach, we propose a set of approximately unbiased estimators. The key results for non-matched CRTs are shown
below. Their matched-pair counterparts and details of the derivations are available in Section B of Online Supplementary
Material 1.
2.3.1 Ratio of mean counts in non-matched CRTs










































with the unknown population mean Y 0⋅1 approximated by the sample mean y0⋅1 to form the sample CV.
2.3.2 Ratio of mean cluster-level event rates in non-matched CRTs





























with the unknown population mean of cluster event rates C0 replaced by the sample estimate to form the sample CV.




















































































with the unknown population mean Y i⋅1 and Pi⋅1 (i = 0, 1) replaced by their sample estimates to form the sample CVs.
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2.3.4 Double ratio of counts in non-matched CRTs
E (r4) and r∗4 can be obtained by replacing r3, pij1 and Pi⋅1 by r4, yij0, and Y i⋅0 in the formula in the previous sub-section on
ratio of event rates.
























































































































































2.3.6 Variances and confidence intervals
























= E[r1 − E (r1)]2 = Var (r1) .




= Var (rl) for l = 2, 3, 4, and 5 as well.











= Var (rl) ∕r∗l
2∀l, where Var (rl) have been given in Equations (2)–(4),
(8), and (13). Confidence intervals (CI) are calculated using the t-distribution with n1 + n0 − 2 degrees of freedom for
non-matched CRTs and n − 1 degrees of freedom for matched-paired CRTs.14 The CIs calculated are then exponentiated
back to the original scale.
















, and then the solutions are plugged into the estimators of Var (r4) and Var (r5), respectively.
Cochran showed that this variance estimator gave a considerable under-estimation.7 In contrast, he showed that the
Jackknife method only mildly over-estimated the variance and the over-estimation vanished quickly as the number of















, l = 3, 4, and 5 and the




For non-matched CRTs, we generated the number of events in the kth group in the jth cluster in the ith trial arm,
conditional on the person-time pijk, by using a Poisson distribution with expected value given by Equation (1). We consid-
ered three sets of intervention effects, representing (a) direct protection (with no indirect effect), (b) direct and indirect
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protection, and (c) no effect, respectively: (a) exp (𝛽D) = 0.5 and exp (𝛽I) = 1; (b) exp (𝛽D) = 0.5 and exp (𝛽I) = 0.75; (c)














takes into account the findings from a




were 0.22, 0.41, and 0.52,
respectively.15 We used positively skewed distributions because that is implied by the sizeable CV(0.6) and positive val-
ues of person-time. We used the rmvnonnormal macro in Stata for the non-normal data generation.16 Additionally, we




= 0.2 or 0.4, as symmetric dis-
tribution is possible under modest CV. A small number of observations (<1% in total) with person-time either below 5 or
above 350 were replaced by 5 or 350, respectively. This is because CRTs often exclude clusters that are very small in size
and exclude or sub-divide very large clusters due to operational and efficiency considerations.5,6 We set the cluster effect,

















is “often ≤ 0.25 and seldom
exceeds 0.5 for most health outcomes”.14
For matched-pair CRTs, we generated the number of events in the ith trial arm in the jth paired cluster (j = 1, 2, … ,n)
by using a Poisson distribution with expected value exp
(
𝛽D,ik + 𝛽I,i + 𝛼ij + 𝛾
)









as following a bivariate normal distribution with means
−2 and SDs 0.05, 0.2, or 0.5 and correlation 0.8. The person-time parameter in the kth group in the jth pair of clusters(
pijk
)




= 0.2, 0.4, or 0.6, skewness 1.5, kurtosis




= 0.2 or 0.4. The
other parameters in the matched-pair CRTs were the same as those in the non-matched CRTs.
In the literature, it has been suggested that non-matched CRTs should include at least four clusters per trial arm and
matched-pair CRTs should include at least six pairs of clusters.1 For non-matched CRTs, we evaluated the properties of the
estimators when the number of clusters per trial arm is 4, 6, 8, 12, 16, 32, and 64. For matched-pair CRTs, we considered
6, 8, 12, 16, 32, and 64 pairs of clusters.
In each scenario, we conducted 10 000 replicates of data generation and in each of them calculated the five asymp-
totically unbiased estimators and the five approximately unbiased estimators and their variances. We report the relative
bias of the mean estimates of the incidence rate ratio, root mean square error (RMSE), coverage probability (CP) of the
95% confidence intervals (CI) and power to reject the null hyperthesis of the respective ratio equals one (or type 1 error
when the null hyperthesis is true). Calculation of CIs was based on log-transformation and then exponentiate back to the
original scale, which were used for statistical inference. Calculations of relative bias and RMSE were based on the ratios
themselves without transformation.
3.2 Simulation results
In Figures 1 to 3 we show the simulation results of non-matched CRTs that the intervention only had a direct effect, that




= 0.4, which was approximately the median level of variability in cluster
size found by a systematic review.15 To maintain visual clarity, we separately present the results on r1, r2, r3, r∗1 , r
∗
2 , and r
∗
3
(upper panel) and r4, r5, r∗4 , and r
∗
5 (lower panel).
Figure 1 shows the patterns of relative bias. All the asymptotically unbiased estimators showed positive relative bias








≤ 0.2, r2, and r3 only showed very mild bias and the two curves mostly overlapped. In
contrast, the approximately unbiased estimators, r∗1 , r
∗
2 , and r
∗
3 , were practically unbiased under all situations considered.




. The approximately unbiased estimators r∗4 and r
∗
5 were
practically unbiased under all situations considered.
In Figure 2, r∗2 and r
∗
3 had smaller RMSE than r
∗
1 , but they converged as ni increased. r
∗





= 0.5 and ni was small. Otherwise they were almost indistinguishable from each other. r∗5 had smaller




but they converged as ni increased. The asymptotically
unbiased estimators had RMSE similar to or slightly larger than their respective approximately unbiased counterparts’,
but the difference vanished as ni increased.





was large (Figure 3). The CP improved as ni increased. The asymptotically unbiased estimators tended to
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F I G U R E 1 Relative bias of intervention effect estimators in relation to the number of clusters per trial arm for non-matched CRTs, by




; population size per cluster follows a skewed distribution with mean = 100 and CV = 0.4; intervention has a direct
effect only (exp (𝛽D) = 0.5; exp (𝛽I) = 1) [Colour figure can be viewed at wileyonlinelibrary.com]
have similar or slightly lower CP than their respective approximately unbiased counterparts. In the upper panel,




. r∗1 and r
∗
3 had CP below 94% in some




. Using the Jackknife-based variance estimator described in Section 2 for
r∗3 , denoted by r
∗
3(J), gave improved CP that was closer to the nominal 95% level than r
∗
3 . In the lower panel, r4,
r5, r∗4 , and r
∗
5 had varying degree of under-coverage in different scenarios. However, using the Jackknife-based vari-
ance estimators for r∗4 and r
∗




5(J), respectively, the CP was close to the nominal level in all
situations.
Figure 4 shows type 1 error rates, that is, rejection of null hypothesis in scenarios with exp (𝛽D) = 1 and exp (𝛽I) =
1. Otherwise, the parameters are the same as those in Figures 1 to 3. There was a tendency for all estimators to




≥ 0.2 and ni < 32. The inflation




1 , performed better than the others. In
the lower panel, r4, r5, r∗4 , and r
∗
5 had varying level of inflation of type 1 error under different parameter settings.
In contrast, r∗4(J) and r
∗
5(J) performed well. In no circumstances did they show more than 1% deviation from the 5%
target.
Figure 5 compares the power of selected estimators that use person-time as denominators, r∗2 and r
∗
3(J), vs selected
estimators that use event counts in the non-target group as denominators, r∗4(J) and r
∗
5(J). We focused on them because
they performed well in terms of CP and type 1 error rate. The lower panel introduced an indirect effect, exp (𝛽I) = 0.75,
in addition to a direct effect, exp (𝛽D) = 0.5. Otherwise, the parameters here are the same as those in Figures 1 to 4. When
there was direct effect only (upper panel), r∗2 and r
∗








≤ 0.2. In contrast,
r∗4(J) and r
∗




= 0.5. Furthermore, r∗5(J) was more powerful than r
∗
4(J) in all the scenarios
considered. With the addition of the indirect effect, r∗2 and r
∗
3(J) were more powerful than r
∗










Further simulation results on non-matched CRTs under other parameter settings and simulation results on
matched-pair CRTs are available in Online Supplementary Material 2. The findings are qualitatively similar to those
reported above. Some relatively important additional information is as follows: First, in non-matched CRTs, the relative
MA et al. 11
F I G U R E 2 Root mean squared error (RMSE) of intervention effect estimators in relation to the number of clusters per trial arm for




; population size per cluster follows a skewed distribution with mean = 100 and CV = 0.4;
intervention has a direct effect only (exp (𝛽D) = 0.5; exp (𝛽I) = 1) [Colour figure can be viewed at wileyonlinelibrary.com]
F I G U R E 3 Coverage probability (CP) of 95% confidence interval (calculated on log-scale and exponentiated back to the original scale)




; population size per cluster follows a
skewed distribution with mean = 100 and CV = 0.4; intervention has a direct effect only (exp (𝛽D) = 0.5; exp (𝛽I) = 1) [Colour figure can be
viewed at wileyonlinelibrary.com]
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population size per cluster follows a skewed distribution with mean = 100 and CV = 0.4; intervention has no effect (exp (𝛽D) = 1; exp (𝛽I) = 1)
[Colour figure can be viewed at wileyonlinelibrary.com]











; population size per cluster follows a skewed distribution with mean = 100 and CV = 0.4. Upper panel: with direct effect only
(exp (𝛽D) = 0.5; exp (𝛽I) = 1); lower panel: with direct and indirect effects (exp (𝛽D) = 0.5; exp (𝛽I) = 0.75) [Colour figure can be viewed at
wileyonlinelibrary.com]
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F I G U R E 6 Design of seasonal malaria chemoprevention (SMC) trial




increased except when the number of cluster was about 32 or above. In





Figures S1 and S2). Second, in non-matched CRTs, the CP of r∗3(J) reduced to about 93% and its type 1 error rate increased








= 0.5 and the number of clusters was 6 or below (eg, Figures S6 and S26). How-
ever, in matched-paired CRTs, r∗,paired3(J) performed well in these aspects while r
∗,paired
2 had somewhat inflated type 1 error
rate and below target CP (eg, Figures S41, S42, S62, and S63).
4 SEASONAL MALARIA CHEMOPREVENTION TRIAL
We use a subset of data from a published study of seasonal malaria chemoprevention (SMC) in Senegalese children
to illustrate.17 The trial set-up is shown in Figure 6. The trial had a total of 54 clusters. It had the appearance of
an “optimal design”,18,19 with nine clusters on intervention (leftmost column) and nine clusters on control condition
(rightmost column) for all three time periods (2008 to 2010) that resembled a non-matched CRT, flanking a standard
stepped-wedge trial (middle columns). The middle columns represent 18 clusters that were randomized to receive SMC
from 2009 and another 18 clusters randomized to receive SMC from 2010. However, the trial was not planned accord-
ing to the optimal design. The original plan was that the trial would continue up to 4 years (2008 to 2011), and the
nine clusters on the rightmost column were randomized to receive SMC in 2011. But the trial was terminated after the
malaria transmission season in 2010 according to data monitoring and interim analysis results. Furthermore, in the
first period (2008), children aged 3 to 59 months in the nine clusters on the leftmost column were given SMC as part of
the preparation of the study logistics. In 2009 and 2010, children aged between 3 months and 9 years (inclusive) were
given SMC.
A passive surveillance system was implemented in health facilities to determine the number of clinical malaria
episodes confirmed by rapid malaria test (primary endpoint) in each cluster, by four age groups (59 months or below;
5-9; 10-19; over 19 years). The data was at the cluster, not individual, level. Mortality data was collected for all age groups
but only data for children aged 9 years or below was used in the previously published analysis17 and available to the
present analysis. Number of deaths (secondary endpoint) and population size of the clusters at mid-September each year
(approximately the beginning of the annual malaria transmission season), by age groups, was collected by a demographic
surveillance system.
For the purpose of illustration, we used the 2008 data from the 18 clusters that resembled a non-matched CRT. Children
aged between 3 to 59 months were the target group. We considered children aged 5 to 9 years the non-target group.
Table 1 shows the descriptive statistics by endpoints and trial arms. It also included a simple average of each statis-
tics in the two trial arms as a summary. There was very large between-cluster variability in malaria incidence rate in




>1 in both arms. In the target group, the CVs of malaria episodes approximately dou-








≈ 0.60∕1.37 = 0.44. The correlation coefficient between




, was weak, with average across trial arms being
only 0.03. The estimates of malaria incidence rate in the SMC and control arms were c1 = 0.0029 > R1 = 0.0028 and





, was strong, averaged at 0.76.
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T A B L E 1 Descriptive summary of number of malaria episodes and deaths, population size and
their correlations and coefficient of variation of cluster-level event rates in 9 intervention clusters and 9
control clusters in a seasonal malaria chemoprevention (SMC) trial in 2008
Malaria Mortality
Statistics SMC Control Average SMC Control Average
yij1 8.00 3.56 5.78 7.11 2.89 5.00
yij0 15.44 5.89 10.67 1.00 0.56 0.78
pij1 2834 1741 2288 2834 1741 2288























































0.988 0.998 0.993 0.988 0.998 0.993
Table 2 shows the estimation results. The estimates based on the asymptotically unbiased estimators were all larger
than those based on the approximately unbiased estimators. Given this number of clusters, we considered the latter
more accurate. For l = 3, 4, and 5, the SE’s based on r∗l(J) were only slightly larger than r
∗
l . All confidence intervals




was weak, the estimated r1 was much larger than r2 and r3, leading to stan-
dard error SE (r1) larger than SE (r2) and SE (r3). Given ci > Ri in both trial arms, SE (r2) < SE (r3). As expected from








, SE (r4) was smaller than SE (r2) and SE (r3).
The estimators for direct effects, r∗4 and r
∗

















in either trial arm, as indicated by Equation (14),
Var (r4) ≅ Var (r5).
Table 1 also shows that the descriptive statistics on mortality. There was less between-cluster variability in mortal-




in the two arms averaged at 0.79. Furthermore, in the target group, the








≈ 0.60∕1.00 = 0.60.
Unlike malaria episodes, the correlation coefficient between deaths and population size of the target group was more
substantial, with average across trial arms being 0.59. The estimates of mortality rate in the SMC and control arms
were c1 = 0.0022 < R1 = 0.0025 and c0 = 0.0018 > R0 = 0.0017, respectively. The correlation between deaths in the tar-




at 0.51; this was weaker than that for malaria
episodes.
Estimation results on mortality are available in Table 2. Again, the asymptotically unbiased estimators tended
to give larger estimates than their respective approximately unbiased estimators. However, the differences between
the two set of estimates were smaller than those on malaria episodes, as expected from the smaller between-cluster
variability in mortality rate than malaria incidence rate. The SE’s based on r∗l(J) were only slightly larger than




was substantial and the esti-









and relatively large 𝜃, SE (r2) and SE (r3) were smaller than SE (r4). There was
















in either trial arm, so
Var (r4) ≅ Var (r5).
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T A B L E 2 Estimates, SE and 95% confidence intervals (CI;
exponentiation of log-transformed values) for malaria and mortality in
seasonal malaria chemoprevention trial data in 2008
Endpoint Estimator Estimate SE 95% CI
Malaria r∗1 1.70 1.45 (0.28, 10.4)
r∗2 0.62 0.67 (0.06, 6.07)
r∗3 1.01 0.97 (0.13, 7.80)
r∗3(J) 1.01 1.00 (0.12, 8.26)
r∗4 0.74 0.37 (0.25, 2.14)
r∗4(J) 0.74 0.40 (0.23, 2.32)
r∗5 0.76 0.38 (0.26, 2.19)
r∗5(J) 0.76 0.41 (0.24, 2.38)
r1 2.25 1.45 (0.57, 8.85)
r2 0.94 0.67 (0.21, 4.24)
r3 1.38 0.97 (0.31, 6.16)
r4 0.86 0.37 (0.34, 2.14)
r5 0.88 0.38 (0.35, 2.20)
Mortality r∗1 2.21 1.16 (0.73, 6.74)
r∗2 1.16 0.46 (0.50, 2.67)
r∗3 1.44 0.58 (0.61, 3.40)
r∗3(J) 1.44 0.61 (0.59, 3.54)
r∗4 1.08 0.81 (0.22, 5.26)
r∗4(J) 1.08 0.88 (0.19, 6.02)
r∗5 1.12 0.83 (0.23, 5.41)
r∗5(J) 1.12 0.91 (0.20, 6.33)
r1 2.46 1.16 (0.90, 6.70)
r2 1.22 0.46 (0.55, 2.70)
r3 1.51 0.58 (0.67, 3.42)
r4 1.37 0.81 (0.39, 4.78)
r5 1.40 0.83 (0.40, 4.92)
5 DISCUSSION
The proposed approximately unbiased estimators successfully reduce the bias when the number of clusters is small. They
also have advantages in terms of smaller RMSE and more accurate coverage probability than the asymptotically unbi-
ased estimators. For studies with fewer than 60 clusters per arm, we recommend the use of the approximately unbiased
estimators. Some CRTs do have a large number of clusters per trial arm, for example, a trial of influenza vaccination had
over 400 nursing homes per arm20 and a trial of mass drug administration had over 700 communities per arm.21 For such
studies, the choice between the asymptotically and approximately unbiased estimators is unimportant. Furthermore,
with a large number of clusters, the simple estimator r1 has performance very similar to r2 and r3. At the study planning
stage, investigators may take into account this finding when they consider the cost and benefit of collecting person-time
data.
Previous simulation studies evaluated the performance of the estimator r2.5,6 We caution that the range of parameter
values they considered were somewhat narrow. From our analytic solution, the estimator is only asymptotically unbiased.
As seen in Equation (15), the bias in the estimator r2 is a non-linear function of the between-cluster variability of event
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rate. From simulation, the bias of r2 became obvious as the variability increased, especially when the number of clusters
per trial arm was below 16 or so. In the SMC study of malaria episodes, where the variability was large, the r2 estimate
was much larger than r∗2 . In those situations, the use of our proposed bias-corrected estimator r
∗
2 is preferable over r2.
While r∗3 performs well in terms of bias and RMSE, its variance estimator under-estimates the true variability as the CV
of cluster size or event rate increases; it approaches the target CP as the number of clusters increases. The under-coverage
can be corrected by plugging the Jackknife estimates of Var (Ri) into the estimator for Var (r3). We found that r∗2 and r
∗
3(J)








= 0.5. In those settings, r∗3(J) had type 1 error rate up
to about 2% higher than the nominal 5% level when the number of clusters was six or below, and r∗2 may be preferred.
However, in matched-pair CRTs, r∗,paired2 did not out-perform r
∗,paired
3(J) . Furthermore, previous studies had shown that the
estimator of cluster-level event rate in a trial arm, ci, is a biased estimator, and the level of bias does not reduce in relation
to increase in number of clusters.8 In contrast, Ri can be used to obtain an asymptotically unbiased estimate of disease
incidence.7,8 Even if r∗2 is used to estimate incidence rate ratio, Ri is preferable over ci as an estimator of the incidence rate
in each trial arm.
Our consideration of r4 and r5 was in part motivated by an evaluation of a malaria vaccine where indirect effects were
unlikely and the incidence of some outcomes such as meningitis (a safety outcome) could be highly variable between
clusters, and where balanced randomization with respect to access to health care facilities (where passive surveillance




is large, the number of events in the target group is likely to be more
strongly correlated with the number of events in the non-target group than with the person-time in the target group.
Furthermore, it is typical that vaccine studies anticipate no indirect effect on safety endpoints. So, these estimators are
expected to estimate the same target as far as safety is concerned. In simulation studies of scenarios that the intervention




was ≤0.2, r∗2 and r
∗







increased to 0.5 and in the malaria data in the SMC trial, r∗4(J) and r
∗
5(J) had substantially smaller SE
than r∗2 and r
∗




5(J) are our estimators of choice. In various scenarios we evaluated, r
∗
5(J)





that case, the magnitude of the benefits may not justify the extra cost in collection of person-time data in both the target
and non-target groups. Otherwise, r∗5(J) tends to be preferable over r
∗
4(J).
We foresee that the estimators that use person-time in the target group and estimators that use number of events in
the non-target groups as a denominator may be used in different parts of the same CRT, depending on the considerations
aforementioned. For example, r2 or r3 or their extensions may be used in efficacy analysis while r4 and r5 or their extensions
may be used in safety analysis.
Furthermore, r4 and r5 are generic quantities in the sense that yij0 may be replaced by quantities other than the number
of events in non-target groups to achieve other purposes. For example, there has been interest in the use of “negative
control events” to remove the bias arising from differential ascertainment of outcome events in non-blinded CRTs.4 The
proposed estimator in the literature is in the form of r4, with y1j0 and y0j0 replaced by the number of negative control events
in the intervention and control arm, respectively.4 The previous study did not consider the properties of the estimator
in situations with small number of clusters. The results here apply directly. Another example of application is to the
CRT with Before and after observations (CRT-BA) design,23 which collects data in a baseline period before launching
the randomized intervention and control comparator. By replacing yij0 by the baseline event count, r4 becomes a baseline
adjusted estimator of the total effect. It offers a robust alternative to the analysis of CRT-BA trials.
The strengths of the present study include coverage of both non-matched and matched-pair CRTs, analytic evaluation
of the bias of existing asymptotically unbiased estimators, proposal of estimators that capitalize on denominators other
than cluster population size and their potential applications, development of a bias-corrected version of these estimators
for use in studies with a small number of clusters, and simulation evaluation of the estimators with a realistic range of
variability in cluster size. A limitation is that the methods do not handle covariate adjustment. However, good use of
restricted randomization may reduce the need for covariate adjustment in the analysis stage.1
In non-matched CRTs, one approach for controlling covariate effects is stratified analysis and pooling of
stratum-specific estimates using weights inversely proportional to variances. The limitation is that it is not practical
to stratify for multiple covariates and it requires categorization of continuous covariates. Another approach is to apply
ANCOVA to cluster-level data. However, it only works for methods that generate a summary value per cluster, such as
r1 and r2, whose calculation begins with getting an event count and event rate per cluster, respectively. This is different
from the calculation of r3 to r5, which begins with generating an estimate for a trial arm. For example, in r3, the incidence
rate in a trial arm is the sum of events over clusters divided by the sum of person-time over clusters within the trial arm.
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There is not a summary value for every cluster. Furthermore, when the purpose is to estimate rate ratio instead of rate
difference, the ANCOVA approach would need to analyze the log-transformed values instead. The exponentiated inter-
vention effect estimate is then interpreted as a ratio of geometric means, which is not the same as the widely used estimator
of ratio of arithmetic means (including r1 and r2). In CRTs with a small number of clusters, the bias and bias-correction for
ratios of geometric means of event counts and event rates have yet to be investigated. Another approach is to use Poisson
regression analysis with cluster-level covariates (and individual-level covariates if available) without using the interven-
tion variable as predictors to obtain an expected number of events for each cluster.5 Comparison of the deviations of the
observed from the expected number of events between trial arms then offers a covariate adjusted estimate for the inter-
vention effect. Following this idea, if yij0 in r4 or pijk in r5 are replaced by this expected number of events, they become
covariate adjusted estimators of the total or direct effect, respectively. The bias-correction method may then be applied to
obtain covariate adjusted r∗4 or r
∗
5 . But the variance estimators may not work well as they do not account for the uncer-
tainty in the prediction of the expected number of events. In short, while there are several candidate approaches available,
challenges remain. Further research is needed to develop and evaluate these or other approaches to covariate adjustment.








tends to dilute this correlation. As such, pilot data and careful consideration of the between-cluster variability in event rate
is important not only for sample size determination but also for choice of study design and statistical analysis procedures.
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APPENDIX A.
T A B L E A1 Estimators of incidence rate ratio for matched-pair cluster randomized trialsa
Label Estimand b Estimator Variance c




































































































































a yijk, pijk, and cij = yij1∕pij1 are, respectively, the number of events, person-time/population size and cluster-level event rates in the cluster that is
randomized to receive the ith trial arm (1 for intervention and 0 for control) in the jth pair of clusters and kth group (1 for target and 0 for non-target




𝛽T and 𝛽D: Total effect and direct effect in terms of log incidence rate ratio.

























































































































































































































j=1pijk∕n, i = 0, 1; k = 0, 1.
